← Evidence map

ReviewCancer medicine2025

Emerging Radiopharmaceuticals Beyond FDG for Ovarian Cancer: A Review of Advances in Nuclear Medicine.

Mara M K Veenstra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40923371